Massachusetts General Hospital (Data Collection Only)

Boston, Massachusetts 02114

4 studies enrolling now · 5 studies all time

What they study most

Adult T-cell Leukemia/Lymphoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T-cell Lymphoma, Breast Implant-Associated Anaplastic Large Cell Lymphoma, Chronic Active EBV Infection of T-and NK-Cell Type, Systemic Form, Chronic Lymphoproliferative Disorder of NK Cells, Enteropathy-associated T-cell Lymphoma, Esophageal Cancer, Esophagogastric Cancer, Extranodal NK/T-cell Lymphoma, Nasal Type

Studies at this site

• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers — Recruiting now
• A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis — Recruiting now
• A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer — Recruiting now
• A Registry for People With T-cell Lymphoma — Recruiting now
• A Study of Amivantamab in People With Esophagogastric Cancer — Running, not enrolling